181 related articles for article (PubMed ID: 3490224)
21. [Immunophenotyping in the differential diagnosis of malignant non-hodgkin's lymphomas].
Dzembak TM; Gurkalo VK; Gershanovich ML
Vopr Onkol; 1996; 42(5):63-6. PubMed ID: 9064906
[TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
23. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
Zinzani PL; Magagnoli M; Pagliani G; Bendandi M; Gherlinzoni F; Merla E; Salvucci M; Tura S
Haematologica; 1997; 82(3):305-8. PubMed ID: 9234576
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic expression of non-Hodgkin's lymphomas in China.
Xu LZ; Tu LY; Liu YF; Hsu SM; Qiu BS; Li ZX
J Natl Cancer Inst; 1984 Sep; 73(3):635-8. PubMed ID: 6236322
[TBL] [Abstract][Full Text] [Related]
25. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
26. Importance of cell surface marker to the prognosis of non-Hodgkin's lymphoma.
Toki H; Okabe K; Kamei H; Segawa Y; Koike S
Acta Med Okayama; 1988 Oct; 42(5):287-92. PubMed ID: 3265575
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
Salter DM; Krajewski AS; Sheehan T; Turner G; Cuthbert RJ; Mclean A
J Pathol; 1989 Nov; 159(3):211-20. PubMed ID: 2593045
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
29. Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Zinzani PL; Tani M; Molinari AL; Stefoni V; Zuffa E; Alinari L; Gabriele A; Bonifazi F; Salvucci M; Tura S; Baccarani M
Haematologica; 2002 Aug; 87(8):816-21. PubMed ID: 12161357
[TBL] [Abstract][Full Text] [Related]
30. A clinical perspective on cell markers in acute lymphocytic leukemia.
Bowman WP; Melvin SL; Aur RJ; Mauer AM
Cancer Res; 1981 Nov; 41(11 Pt 2):4794-801. PubMed ID: 6975162
[TBL] [Abstract][Full Text] [Related]
31. A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas.
Novakovic BJ; Novakovic S; Frkovic-Grazio S
Oncol Rep; 2006 Jul; 16(1):191-5. PubMed ID: 16786145
[TBL] [Abstract][Full Text] [Related]
32. Immunologic complexity of lymphoblastic lymphoma.
Grogan T; Spier C; Wirt DP; Hicks MJ; Paquin M; Hutter J; Miller T; Rangel C; Richter L; Jones S
Diagn Immunol; 1986; 4(2):81-8. PubMed ID: 3086016
[TBL] [Abstract][Full Text] [Related]
33. Expression of Tac antigen in B cell lymphomas.
Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
[TBL] [Abstract][Full Text] [Related]
34. Correlation of morphology, immunophenotype, and flow cytometry with remission induction and survival in high grade non-Hodgkin's lymphoma.
O'Brien CJ; Holgate C; Quirke P; Stuart NS; Ellis IO; Elston CW; Jones EL; Bird CC
J Pathol; 1989 May; 158(1):31-9. PubMed ID: 2754538
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.
Jalkanen S; Joensuu H; Söderström KO; Klemi P
J Clin Invest; 1991 May; 87(5):1835-40. PubMed ID: 2022749
[TBL] [Abstract][Full Text] [Related]
36. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.
Bloomfield CD; Gajl-Peczalska KJ; Frizzera G; Kersey JH; Goldman AI
N Engl J Med; 1979 Sep; 301(10):512-8. PubMed ID: 313510
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical staining of non-Hodgkin's lymphoma in paraffin sections using the MB1 and MT1 monoclonal antibodies.
Dobson CM; Myskow MW; Krajewski AS; Carpenter FH; Horne CH
J Pathol; 1987 Nov; 153(3):203-12. PubMed ID: 3323430
[TBL] [Abstract][Full Text] [Related]
39. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas.
Borowitz MJ; Croker BP; Metzgar RS
Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233
[TBL] [Abstract][Full Text] [Related]
40. [A study of non-Hodgkin's lymphoma (author's transl)].
Kotoo Y
Fukuoka Igaku Zasshi; 1978 Feb; 69(2):73-82. PubMed ID: 306366
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
